Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Therapy for hepatic fibrosis: revisiting the preclinical models.

Bissell DM.

Clin Res Hepatol Gastroenterol. 2011 Sep;35(8-9):521-5. doi: 10.1016/j.clinre.2011.03.009. Epub 2011 May 4. Review. No abstract available.

PMID:
21536514
2.

[Therapeutical targets for revert liver fibrosis].

García B L, Gálvez G J, Armendáriz B J.

Rev Med Chil. 2007 Jun;135(6):783-91. Epub 2007 Aug 22. Review. Spanish.

3.
4.

Liver fibrosis and therapeutic strategies: the goal for improving metabolism.

Balsano C, Alisi A, Nobili V.

Curr Drug Targets. 2009 Jun;10(6):505-12. Review.

PMID:
19519352
5.

Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference.

Friedman SL, Rockey DC, Bissell DM.

Hepatology. 2007 Jan;45(1):242-9.

PMID:
17187439
6.

Cirrhosis--can we reverse hepatic fibrosis?

Tangkijvanich P, Yee HF Jr.

Eur J Surg Suppl. 2002;(587):100-12. Review.

PMID:
16144208
7.

Apoptosis and liver fibrosis: antifibrotic strategies.

Calès P.

Biomed Pharmacother. 1998;52(6):259-63. Review.

PMID:
9755825
8.

A target role for mast cell in the prevention and therapy of hepatic fibrosis.

Shen DZ.

Med Hypotheses. 2008;70(4):760-4. Epub 2007 Oct 4.

PMID:
17919831
9.

[Persectives on postgenome medicine: Gene therapy for liver cirrhosis].

Ueki T, Okamoto E, Takeuchi M, Fujimoto J.

Nihon Rinsho. 2001 Jan;59(1):152-6. Review. Japanese.

PMID:
11197847
10.

[Progress in gene therapy of liver cirrhosis].

Yang R, Gao J.

Sheng Li Ke Xue Jin Zhan. 2004 Jan;35(1):30-4. Review. Chinese.

PMID:
15127594
11.

Systematic review: hepatic fibrosis - regression with therapy.

Zois CD, Baltayiannis GH, Karayiannis P, Tsianos EV.

Aliment Pharmacol Ther. 2008 Nov 15;28(10):1175-87. doi: 10.1111/j.1365-2036.2008.03840.x. Epub 2008 Aug 30. Review.

12.

Differentiation of mouse hepatic progenitor cells induced by hepatocyte nuclear factor-4 and cell transplantation in mice with liver fibrosis.

Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T, Moriwaki H.

Transplantation. 2008 Nov 15;86(9):1178-86. doi: 10.1097/TP.0b013e31818a8233.

PMID:
19005397
13.

Targeted RNA interference for hepatic fibrosis.

Hu PF, Xie WF.

Expert Opin Biol Ther. 2009 Oct;9(10):1305-12. doi: 10.1517/14712590903213677. Review.

PMID:
19723017
14.

[Forefront of therapy for hepatic fibrosis].

Ueno T, Sata M.

Nihon Shokakibyo Gakkai Zasshi. 2002 Apr;99(4):365-78. Review. Japanese. No abstract available.

PMID:
11979734
15.

Reversibility of hepatic fibrosis: from the first report of collagenase in the liver to the possibility of gene therapy for recovery.

Okazaki I, Watanabe T, Hozawa S, Niioka M, Arai M, Maruyama K.

Keio J Med. 2001 Jun;50(2):58-65. Review.

16.

[Genetic risk factors for hepatic fibrosis in chronic liver diseases].

Wasmuth HE, Lammert F, Matern S.

Med Klin (Munich). 2003 Dec 15;98(12):754-62. Review. German.

PMID:
14685677
17.

Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model.

Shimamura T, Fujisawa T, Husain SR, Kioi M, Nakajima A, Puri RK.

J Immunol. 2008 Oct 1;181(7):4656-65.

18.

Hepatic stellate cells and the reversal of fibrosis.

Kisseleva T, Brenner DA.

J Gastroenterol Hepatol. 2006 Oct;21 Suppl 3:S84-7. Review.

PMID:
16958681
19.

The role of the renin-angiotensin system in liver fibrosis.

Munshi MK, Uddin MN, Glaser SS.

Exp Biol Med (Maywood). 2011 May 1;236(5):557-66. doi: 10.1258/ebm.2011.010375. Epub 2011 Apr 20. Review.

PMID:
21508249
20.

Hepatic fibrosis: can we treat it clinically?

Das K, Chowdhury A.

Trop Gastroenterol. 2008 Apr-Jun;29(2):76-83. Review.

PMID:
18972766

Supplemental Content

Support Center